Literature DB >> 23732023

The natural history of cervical human papillomavirus infections and cervical cancer: gaps in knowledge and future horizons.

Cosette Marie Wheeler1.   

Abstract

Genital human papillomavirus (HPV) infection is the most common sexually transmitted infection. Most HPV infections are benign and resolve on their own, but some women develop persistent HPV infections. Persistent HPV infection with certain high-risk HPV genotypes is the necessary cause of most epithelial lesions of the uterine cervix. The importance of latent or quiescent HPV, waning immunity, hormonal milieu, microbiota, and other factors modifying the natural history of HPV infections across a woman's lifetime deserves further study. Promising biomarkers are emerging that may aid in defining which HPV-infected women are at risk of developing invasive cervical cancer.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23732023     DOI: 10.1016/j.ogc.2013.02.004

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  11 in total

1.  Microbiota dysbiosis is associated with HPV-induced cervical carcinogenesis.

Authors:  Wojciech Kwasniewski; Maria Wolun-Cholewa; Jan Kotarski; Wojciech Warchol; Dorota Kuzma; Anna Kwasniewska; Anna Gozdzicka-Jozefiak
Journal:  Oncol Lett       Date:  2018-09-26       Impact factor: 2.967

2.  Clinical characteristics of women diagnosed with carcinoma who tested positive for cervical and anal high-risk human papillomavirus DNA and E6 RNA.

Authors:  Carlos A R Veo; Sarhan S Saad; José Humberto T G Fregnani; Cristovam Scapulatempo-Neto; Audrey Tieko Tsunoda; Júlio César Possati Resende; Adriana Tarlá Lorenzi; Allini Mafra; Claudia Cinti; Ismael Dale Cotrim; Luciana Albina Reis Rosa; Cristina Mendes de Oliveira; Toni Ricardo Martins; Cristiane Centrone; José Eduardo Levi; Adhemar Longatto-Filho
Journal:  Tumour Biol       Date:  2015-02-13

3.  The role of acquired immunity in the spread of human papillomavirus (HPV): explorations with a microsimulation model.

Authors:  Suzette M Matthijsse; Joost van Rosmalen; Jan A C Hontelez; Roel Bakker; Inge M C M de Kok; Marjolein van Ballegooijen; Sake J de Vlas
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

Review 4.  Human papillomavirus and head and neck carcinomas: focus on evidence in the babel of published data.

Authors:  P Morbini; M Benazzo
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-08       Impact factor: 2.124

5.  An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.

Authors:  Espen Enerly; Ragnhild Flingtorp; Irene Kraus Christiansen; Suzanne Campbell; Mona Hansen; Tor Åge Myklebust; Elisabete Weiderpass; Mari Nygård
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

6.  Changes of vaginal microbiota during cervical carcinogenesis in women with human papillomavirus infection.

Authors:  Kyeong A So; Eun Jung Yang; Nae Ry Kim; Sung Ran Hong; Jae-Ho Lee; Chang-Sun Hwang; Seung-Hyuk Shim; Sun Joo Lee; Tae Jin Kim
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

7.  Assessment of high-risk human papillomavirus infections using clinician- and self-collected cervical sampling methods in rural women from far western Nepal.

Authors:  Derek C Johnson; Madhav P Bhatta; Jennifer S Smith; Mirjam-Colette Kempf; Thomas R Broker; Sten H Vermund; Eric Chamot; Shilu Aryal; Pema Lhaki; Sadeep Shrestha
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

Review 8.  Influence of the tryptophan-indole-IFNγ axis on human genital Chlamydia trachomatis infection: role of vaginal co-infections.

Authors:  Ashok Aiyar; Alison J Quayle; Lyndsey R Buckner; Shardulendra P Sherchand; Theresa L Chang; Arnold H Zea; David H Martin; Robert J Belland
Journal:  Front Cell Infect Microbiol       Date:  2014-06-03       Impact factor: 5.293

9.  Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.

Authors:  Dongman Zhao; Liran Zhang; Fengxiang Xie; Dezhi Peng; Jie Wei; Lingbo Jiang; Shoudu Zhang; Debo Qi
Journal:  BMC Cancer       Date:  2020-08-26       Impact factor: 4.430

10.  [Prevalence of non-vaccinable high risk genotypes of human papillomavirus in the Early Detection of Cervical Cancer Program in Cantabria].

Authors:  María Paz-Zulueta; Ana Fernández-Feito; Marina Amparán Ruiz; Asunción Azofra Olave; Yolanda Martín Seco; Sonia Ojugas Zabala; Aurora Otero García; Carmen Royano Rasines; Raquel Sarabia-Lavín; Blanca Torres Manrique; Miguel Santibáñez Margüello
Journal:  Aten Primaria       Date:  2015-10-29       Impact factor: 1.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.